Evidence map›Paper›PMID 36692907›Full record

ArticleJournal of managed care & specialty pharmacy2023

Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system.

Albert Chien, Sneha Thanasekaran, Angela Gaetano, Glen Im, Kael Wherry, Janice MacLeod, Robert A Vigersky

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Observational
  4. A primer on clinical programs in managed care pharmacy.Journal of managed care & specialty pharmacy · 2026
    Review
  5. Observational
  6. Review
  7. Advances in Continuous Glucose Monitoring: Clinical Applications.Endocrinology and metabolism (Seoul, Korea) · 2025
    Review
  8. Connected Insulin Pens and Pen Caps: Expanding Diabetes Technology Access and Adoption.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  9. Advances in diabetes technology within the digital diabetes ecosystem.Journal of managed care & specialty pharmacy · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Albert ChienMedtronic Diabetes, Northridge, CA.
Sneha ThanasekaranMedtronic Diabetes, Northridge, CA.
Angela GaetanoMedtronic Diabetes, Northridge, CA.
Glen ImMedtronic Diabetes, Northridge, CA.
Kael WherryMedtronic Diabetes, Northridge, CA.
Janice MacLeodMedtronic Diabetes, Northridge, CA.
Robert A VigerskyMedtronic Diabetes, Northridge, CA.
Medtronic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2HypoglycemiaBlood GlucoseBlood Glucose Self-MonitoringCost SavingsGlucoseHumansHypoglycemic AgentsInsulinUnited StatesBlood GlucoseGlucoseHypoglycemic AgentsInsulin

Identifiers

PMID36692907
PMCPMC10394220
OpenAlexW4317870236

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.